Thomas A. Louis

Thomas A. Louis

Auto-generated profile, based on publicly available information

Thomas A. Louis

Johns Hopkins Bloomberg School of Public Health

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2008 in Biostatistics
Verified
Journal Article
Open access
PDF file
TLThomas A. Louis
Thomas A. Louis
SZScott L. Zeger
Scott L. Zeger
When reporting estimates and associated standard errors (ses) or confidence intervals (CIs), the standard formats, “estimate (se)” and “estimate (95% CI: [lower, upper]),” can be confusing in text; in tables they hinder comparisons. Furthermore, some readers can misinterpret the CI format as indicating equal support for all reported values. To remedy these deficits, we recommend formats that (1) improve clarity in text and tables and (2) emphasize that an estimate and its associated uncertainty should be “connected at the hip” as a single unit.

1 June 2009 in Journal of the American Statistical Association
Verified
Journal Article
Closed access
HCHaitao Chu
Haitao Chu
SCSining Chen
Sining Chen
TLThomas A. Louis
Thomas A. Louis
In studies of the accuracy of diagnostic tests, it is common that both the diagnostic test itself and the reference test are imperfect. This is the case for the microsatellite instability test, which is routinely used as a prescreening procedure to identify individuals with Lynch syndrome, the most common hereditary colorectal cancer syndrome. The microsatellite instability test is known to have imperfect sensitivity and specificity. Meanwhile, the reference test, mutation analysis, is also imperfect. We evaluate this test via a random effects meta-analysis of 17 studies. Study-specific random effects account for between-study heterogeneity in mutation prevalence, test sensitivities and specificities under a nonlinear mixed effects model and a Bayesian hierarchical model. Using model selection techniques, we explore a range of random effects models to identify a best-fitting model. We also evaluate sensitivity to the conditional independence assumption between the microsatellite instability test and the m...

20 March 2019 in The American Statistician
Verified
Journal Article
Open access
NBNaomi C Brownstein
Naomi C Brownstein
TLThomas A. Louis
Thomas A. Louis
AOAnthony O’HAgan
Anthony O’HAgan
JPJane Pendergast
Jane Pendergast
This article resulted from our participation in the session on the “role of expert opinion and judgment in statistical inference” at the October 2017 ASA Symposium on Statistical Inference. We present a strong, unified statement on roles of expert judgment in statistics with processes for obtaining input, whether from a Bayesian or frequentist perspective. Topics include the role of subjectivity in the cycle of scientific inference and decisions, followed by a clinical trial and a greenhouse gas emissions case study that illustrate the role of judgments and the importance of basing them on objective information and a comprehensive uncertainty assessment. We close with a call for increased proactivity and involvement of statisticians in study conceptualization, design, conduct, analysis, and communication.

6 April 2012 in Science
Verified
Journal Article
Closed access
PDF file
MDMarie Davidian
Marie Davidian
TLThomas A. Louis
Thomas A. Louis
Popular media and science publications sound the drum: “Big Data” will drive our future, from translating genomic information into new therapies, to harnessing the Web to untangle complex social interactions, to detecting infectious disease outbreaks. Statistics is the science of learning from data, and of measuring, controlling, and communicating uncertainty; and it thereby provides the navigation essential for controlling the course of scientific and societal advances. This field will become ever more critical as academia, businesses, and governments rely increasingly on data-driven decisions, expanding the demand for statistics expertise.

19 November 2009 in Respiratory Research
Verified
Journal Article
Open access
PDF file
JDJeanine M D'ARmiento
Jeanine M D'ARmiento
SSSteven M Scharf
Steven M Scharf
MRMichael D. Roth
Michael D. Roth
JCJohn E Connett
John E Connett
AGAndrew Ghio
Andrew Ghio
RFRobert F Foronjy
Robert F Foronjy
Background: The major marker utilized to monitor COPD patients is forced expiratory volume in one second (FEV1). However, asingle measurement of FEV1 cannot reliably predict subsequent decline. Recent studies indicate that T lymphocytes and eosinophils are important determinants of disease stability in COPD. We therefore measured cytokine levels in the lung lavage fluid and plasma of COPD patients in order to determine if the levels of T cell or eosinophil related cytokines were predictive of the future course of the disease.Methods: Baseline lung lavage and plasma samples were collected from COPD subjects with moderately severe airway obstruction and emphysematous changes on chest CT. The study participants were former smokers who had not had a disease exacerbation within the past six months or used steroids within the past two months. Those subjects who demonstrated stable disease over the following six months (ΔFEV1 % predicted = 4.7 ± 7.2; N = 34) were retrospectively compared with study participants who experienced a rapid decline in lung function (ΔFEV1 % predicted = -16.0 ± 6.0; N = 16) during the same time period and with normal controls (N = 11). Plasma and lung lavage cytokines were measured from clinical samples using the Luminex multiplex kit which enabled the simultaneous measurement of several T cell and eosinophil related cytokines.Results and Discussion: Stable COPD participants had significantly higher plasma IL-2 levels compared to participants with rapidly progressive COPD (p = 0.04). In contrast, plasma eotaxin-1 levels were significantly lower in stable COPD subjects compared to normal controls (p < 0.03). In addition, lung lavage eotaxin-1 levels were significantly higher in rapidly progressive COPD participants compared to both normal controls (p < 0.02) and stable COPD participants (p < 0.05).Conclusion: These findings indicate that IL-2 and eotaxin-1 levels may be important markers of disease stability in advanced emphysema patients. Prospective studies will need to confirm whether measuring IL-2 or eotaxin-1 can identify patients at risk for rapid disease progression.

2 May 2008 in Health Services and Outcomes Research Methodology
Verified
Journal Article
Closed access
PDF file
SRSowmya R. Rao
Sowmya R. Rao
BGBarry Graubard
Barry Graubard
CSChristopher H. Schmid
Christopher H. Schmid
SMSally C. Morton
Sally C. Morton
TLThomas A. Louis
Thomas A. Louis
DFDianne M. Finkelstein
Dianne M. Finkelstein